Akero Therapeutics’s $220 Million Registered Direct Offering

Pietro Martinoia
Tagged:

Goodwin advised Akero Therapeutics on the offering, and Cooley advised the underwriter involved.Akero Therapeutics (Nasdaq: AKRO) announced the closing of its underwritten registered direct offering of…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Pietro Martinoia

…

This content is for Standard 1 Year members only.
Login Join Now